Skip to main content
. 2022 Nov 15;14(11):8085–8102.

Figure 9.

Figure 9

Correlations of risk score with chemotherapy sensitivity and immune therapy. A-L: The IC50 of axitinib, AKT inhibitor VIII, A.770041, roscovitine, vinorelbrine, docetaxel, rapamycin, pyrimethamine, metformin, blenomycin, cisplatin, and salubrinal in the two risk groups. M, N: Effect of cuproptosis score on immunotherapy in the IMvigor and GSE78200 datasets.